Healthcare & Life Sciences

Neuroluna Therapeutics AG

Switzerland

seed

Stage

About

Neuroluna Therapeutics AG is a Basel-based biotechnology company developing therapies for neurodegenerative diseases associated with immune dysfunction.

Explore Neuroluna Therapeutics AG's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.